Figure 1.
Structures of reported PAR4 competitive and noncompetitive inhibitors 1–8. All of the known ligands show poor CNS penetration and/or, in the case of 3–8, insufficient potency at γ-thrombin and unacceptable DMPK profiles.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.